These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1732628)

  • 1. Enhancement of bacillus Calmette-Guerin attachment to the urothelium by removal of the rabbit bladder mucin layer.
    Badalament RA; Franklin GL; Page CM; Dasani BM; Wientjes MG; Drago JR
    J Urol; 1992 Feb; 147(2):482-5. PubMed ID: 1732628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of bacillus Calmette-Guerin attachment to the bladder wall: experimental study].
    Shen Z; Ding G; Chen Z
    Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):951-3. PubMed ID: 16201181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bovine bladder mucin fractions that inhibit Escherichia coli adherence to the mucin deficient rabbit bladder.
    Ruggieri MR; Balagani RK; Rajter JJ; Hanno PM
    J Urol; 1992 Jul; 148(1):173-8. PubMed ID: 1613864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.
    Hudson MA; Brown EJ; Ritchey JK; Ratliff TL
    Cancer Res; 1991 Jul; 51(14):3726-32. PubMed ID: 2065329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of heparin on the adherence of five species of urinary tract pathogens to urinary bladder mucosa.
    Ruggieri MR; Hanno PM; Levin RM
    Urol Res; 1984; 12(4):199-203. PubMed ID: 6437032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.
    Shen ZJ; Wang Y; Ding GQ; Pan CW; Zheng RM
    World J Urol; 2007 Oct; 25(5):525-9. PubMed ID: 17665201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.
    Kavoussi LR; Brown EJ; Ritchey JK; Ratliff TL
    J Clin Invest; 1990 Jan; 85(1):62-7. PubMed ID: 2404029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
    Hudson MA; Yuan JJ; Catalona WJ; Ratliff TL
    J Urol; 1990 Dec; 144(6):1362-4. PubMed ID: 2231927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
    Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
    J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on attachment of bacillus Calmette-Guerin to bladder wall with different types of injury].
    Ding GQ; Shen ZJ; Chen ZD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):65-7. PubMed ID: 14966944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology.
    Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA
    J Urol; 2016 Jun; 195(6):1903-10. PubMed ID: 26694905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
    Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
    J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible influence of antibiotics on results of bacillus Calmette-Guérin intravesical therapy for superficial bladder cancer.
    van der Meijden PM; van Klingeren B; Steerenberg PA; de Boer LC; de Jong WH; Debruyne FM
    J Urol; 1991 Aug; 146(2):444-6. PubMed ID: 1856950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poncet's disease after the intravesical instillation of Bacillus Calmette-Guérin (BCG): a case report.
    Sampaio PCM; Lira YG; Ribeiro HYU; de Paula Moreira F; Gadelha MSM; da Cruz SFS
    BMC Res Notes; 2017 Aug; 10(1):416. PubMed ID: 28821265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.
    Ferrari KL; de Camargo JA; Rocha GZ; Carvalheira JB; Saad MJ; Billis A; Reis LO
    J Urol; 2015 Feb; 193(2):682-9. PubMed ID: 25200808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect.
    Parsons CL; Shrom SH; Hanno PM; Mulholland SG
    Invest Urol; 1978 Nov; 16(3):196-200. PubMed ID: 30735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
    Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
    Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.